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SUMMARY 
Search for a safe and eflective analgesic is long and elusi\e. Buprenorphine was marketed as a potent and non-
addictive narcotic drug. In recent years tliere have been various case reports highlighting its abuse potential. As 
the drug will be used more widely and particularly with its use in the detoxification of heroin dependence there is an 
eminent possibililv of its abuse at larger scale in future. Physicians should be careful in its prescription and cases of 
its abuse should be actively sought tor. A case report along with literature review is presented here. 
Buprenorphinc was introduced asapotent, 
non-addictive analgesic. It is 25-50 times 
more potent than morphine (Jaffe et al., 
1985). It has milder euphoriant effect and 
minimal withdrawal symptoms. It is a 
partial agonist to receptors. It produces 
morphine-like effect at low doses and exhi-
bits ceiling effects at doses equivalent to 30-
60 mg of morphine. Because of ceiling 
effects the risk of overdose may be limited. 
For these reasons buprenorphine was thought 
to be "an analgesic of low abuse potential" 
(Jasinski et al., 1978). 
Recently it is being used in the detoxifi-
cation of narcotic addiction. It has also 
been reported as an alternative to methadone 
in opiate maintenance programs. Jasinski 
et al. (1978) reported that buprenorphine 
when given chronically, blocks the 
subjective effects of parenteral morphine 
or heroin. Chronic hero
:.n users sharply 
reduce their heroin intake when main-
tained on subcutaneous buprenorphine 
(Mello ct al., 1980). It may be because of 
its both agonist and antagonist properties at 
the opiate receptors. 
High analgesic effect, minimal withdrawal 
symptoms, and its efficacy in the manage-
ment of narcotic addiction make it a unique 
drug. However, the recent experience rela-
tes a different story altogether. Buprenor-
phine seems to be a drug with ample poten-
tial for abuse. There are few reports of its 
abuse in the world literature over last 4-5 
years. Paucity of reports may be due to 
short experience with this drug. We are 
reporting a case of buprenorphine abase. 
CASE 
A 32 years old man presented with a 
13 years history of alcohol abuse, 4 years 
history of Pentazocin abuse and 3 years 
history ol Buprenorphine abuse. He 
had been taking later two drugs intra-
venously. His alcohol abuse was preci-
pitated after a failure in love. His average 
daily alcohol consumption increased to 540 
ml over a period of two years. He used to 
remain drunk for the better part of the day. 
He took alcohol in the morning on empty 
stomach, had craving for it, and used to 
have morning shakes. In 1984, he was 
introduced to injection Pentazocin. He star-
ted taking 4-10 ampules of it a day. He 
found it more pleasant and it did not give 
the "stink" of alcohol that used to "drive 
people away''. A year later he met with an 
automobile accident while under the influence 
ofalcohol and pentazocin. He susta
:ned head 
injury with unconsciousness for half-an-hour. 
He recovered uneventfully. Subsequently, 
he had cough and hemoptysis and pulmo-
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nary tuberculosis was diagnosed. He was 
treated accordingly. 
In late 1985 he was introduced to injec-
tion buprenorphine, a "new drug" by a 
pharmacist who used to sell him pentazocin 
ampules. He liked the experience with 
buprenorphine. He used to take 2-1 
ampules of buprenorphine along with 4-10 
ampules of pentazocin and 2-4 ampules of 
diazepam a day intravenously. He was ad-
mitted to a psychiatric facility for a month 
in 1986. He was put on disulfiram. He re-
mained abstinent from alcohol for a short 
time but restarted I. V- buprenorphine, 
pentazocin and diazepam after three months 
of hospita'ization. To obtain these drugs he 
borrowed money heavily, sold away house-
hold articles, and stole money. 
He had tried morphine, pethidine, mctha-
qualone and LSD also. He did not like the 
experience of any of these drugs. They did 
not "suit" h'm. He used to have very un-
pleasant dryness of mouth, a choking sensa-
tion in the throat, weakness, and dysphoria 
with morphuie and pethidine. 
He was admitted to our hospital on four-
teenth April, '88. He had his last injection 
three days ago. He was noted to have mild 
withdrawal features of resdessness, uneasi-
ness, pains and aches, cold sweats, and 
goose flesh for next two days. He was detoxi-
fied with clonidine uneventfully. He was 
discharged after 41 days of hospital stay. 
Since then he is lost to follow up. 
DISCUSSION 
The pat
:ent was dependent on buprenor-
phine and pentazocine. He had withdrawal 
features on stopping the abuse. It is interes-
ting to note dysphoric reaction due to mor-
phine and pethidine "in him. It may De due to 
differential effects of drugs onopiod receptors. 
Harper (1983) was first to report bupre-
norphine abuse in New Zealand. He repor-
ted that buprenorphine "can induce a state 
of physical dependence which leads to drug-
seeking behaviour even though the with-
drawal syndrome is mild." In Germany, 
Richert ct al. (1983) reported three cares of 
buprenorphine dependence. These cases had 
no previous history of opiate addiction. They 
were treated lor moderate lo severe pain 
witli buprenorphine. Since then its abuse 
has been reported by various workers (Ouig-
ley et al., 1984; Strange, 1983; Robertson 
et al., 1986, 1987; O'Connor et al., 1988^. 
Strange (1985) reported from Greater Man-
chester of tablets of buprenorphine being crus-
hed and taken intravenously. He emphasized 
caution in the use of buprenorphine. Robert-
son (1986) reported buprenorphine to be the 
"drug of choice" abused intravenously in 
Edinburgh. O'Connor et al. (I988"i reported 
a phenomenal rise in the abuse of buprenor-
phine in Dublin. Over one year period it 
rose from nil to 89%. Decline in the purity 
of heroin, easy availability of buprenorphine 
and the fact that the tablets may be crushed 
and taken intravenously may be some of the 
reasons for increased abuse of buprenorphine. 
Buprenorphine has also been reported 
to be psychotogenic. Paraskeviades (1988) 
reported near fatal auditory hallucination 
on taking single tablet of buprenorphine in 
a 50 year old man with no history of mental 
illness. MacEvilly el al. (1989,. reported 
live cases of hallucinations after epidural 
buprenorphine infusion. However, in litis 
series none of the cases seem to have genuine 
hallucinations. They had either nightmare, 
illusions or thought disorder. Yet it is evi-
dent ihat buprenorphine may cause psycho-
tic symptoms. 
In this era of substance abuse, it is a 
matter of genuine concern. There should 
be, awareness of potel tial hazards in using 
buprenorphine. Opiates no matter how 
innocuous they look should be approached 
with caution. Even cough linetus contain-
ing cofleine has been reported to be addic-
tive (Horde et al., 1988 . In the manage-
ment of pain or in the detoxification of narro-200  S. HAQUE NIZAMIE & L. N. SHARMA 
tic addiction buprenorphine should be used 
with caution. Otherwise we may be condem-
ned to repeat the experience with methadone. 
Cases of buprenorphine abuse should be 
actively sought for and those who are pres-
cribed buprenorphine should be closely 
followed up. 
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